Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details) - Schedule of Warrants Outstanding

v3.23.3
Stockholders' Deficit (Details) - Schedule of Warrants Outstanding - $ / shares
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Class of Warrant or Right [Line Items]    
Beginning balance, outstanding 51,465,978  
Issued  
Exercised (in Dollars per share)  
Expired (in Dollars per share)  
Ending balance, outstanding 51,465,978 51,465,978
2019 Public Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share) [1]   $ 230
Expiration Date [1]   Jun. 19, 2024
Beginning balance, outstanding [1] 5,813,804  
Issued [1]  
Exercised (in Dollars per share) [1]  
Expired (in Dollars per share) [1]  
Ending balance, outstanding [1] 5,813,804 5,813,804
Common Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share) [2]   $ 0.37
Expiration Date [2]   Jun. 29, 2027
Beginning balance, outstanding [2] 43,478,261  
Issued [2]  
Exercised (in Dollars per share) [2]  
Expired (in Dollars per share) [2]  
Ending balance, outstanding [2] 43,478,261 43,478,261
Underwriter Warrants [Member]    
Class of Warrant or Right [Line Items]    
Exercise Price (in Dollars per share) [2]   $ 0.37
Expiration Date [2]   Jun. 29, 2027
Beginning balance, outstanding [2] 2,173,913  
Issued [2]  
Exercised (in Dollars per share) [2]  
Expired (in Dollars per share) [2]  
Ending balance, outstanding [2] 2,173,913 2,173,913
[1] The 2019 Public Warrants are exercisable for 290,690 shares of Common Stock at $230.00 per share or a ratio of 20 warrants for one share of Common Stock.
[2] In connection with the PIPE Investment, the exercise price of the Common Warrants and Underwriter Warrants was reduced from $0.88 per shares to $0.37 per share and are exercisable for a combined amount of 2,282,609 shares of Common Stock at $0.37 per share or a ratio of 20 warrants for one share of Common Stock.